To all concerned

Company:
Representative:
Contact:

January 26, 2018
FINDEX Inc.
President & CEO
Teruo Aibara(Securitites code: 3649)
Director and Head ofAdministration
Atsushi Fujita(TEL: +81-89-947-3388)

Notice on Business Alliance Basic Agreement Reached with Canon Medical Systems Corporation

FINDEX Inc. hereby announces that its Board of Directors has resolved at the meeting held today to sign abasic agreement on a medical information system business alliance with Canon Medical Systems
Corporation (Headquarters: Otawara-shi, Tochigi, JAPAN, President: Toshio Takiguchi) as follows:

1. Purpose of the business alliance:
In addition to provide a wide range of systems to consolidate information including examination data anddocument data held by medical institutions for efficient use of that data, our group will endeavor to gather,integrate, analyze and visualize healthcare data and other data managed by the systems under open
circumstances and develop projects that contribute to the national policies, such as telemedicine, medical
cost reduction, health management for the Japanese people, promotion of preventive healthcare andoperation safety management.
In the medical industry, the technology is rapidly progressing, hence the constant change of the market
and the suitable approaches to it. In the aim of keep providing the best products and services at all times tothe industry in these circumstances, or even create markets through technological innovations, these twocompanies, each with a powerful presence in the medical system industry have started a business allianceunder the concept of vendor-neutral to enjoy greater synergistic effects by complementing each other's
mutual strengths.
2. Details of business alliance
Since the best features of Canon Medical Systems lies within the computed tomography (CT) systems,diagnostic X-ray systems and magnetic resonance imaging (MRI) systems, by combining our product with
their medical information integrated management system that mangaes data stored in these radiation
systems, we will drastically improve diagnostic efficiency and data management at medical institutions.
We also aim to promote sales of products of the two companies including new products by setting up a
research and development alliance and making use of the Canon Medical Systems sales network as well as
its excellent human resources across the nation. The two companies will meet, mutually discuss details andmake decisions.

13. Overview of the allaince(1) Company name

Canon Medical Systems Corporation(2) Location

1385 Shimoishigami, Otawara-shi, Tochigi, JAPAN(3) President's name and title

Toshio Takiguchi, Representative Director and President(4) Scope of business

Development, design, manufacture and sale and technicalservices of medical equipment (including diagnostic X-raysystems, CT systems, MRI systems, diagnostic ultrasoundsystems, radiation therapy systems, diagnostic nuclear
medicine systems, medical sample testing systems, andhealthcare IT solutions)(5) Capitalization

20,700,000,050 yen(6) Date of incorporation

September 23, 1948 (Date of foundation: October 10, 1930)(7) Major shareholder and shareholding ratio Canon Inc.: 99%, Canon U.S.A., Inc.: 1%(8) Relationship between the listedcompany and the businessalliance partner company

Capital relationship

No corresponding relationship.

Personal relationship

No corresponding relationship.

Business relationshipWe have accepted an order for medial
information systems from said company.

Corresponding situation ofrelated parties
No corresponding relationship.
(9) Results of operations and financial condition of said company for the most recent three years
Accounting period

For the term ended
March 31, 2015

For the term ended
March 31, 2016

For the term ended
March 31, 2017

Net assets

70,432 million yen

63,471 million yen-

Total assets

196,170 million yen

249,789 million yen-

Consolidated net asset per share

521.80 yen

-

-

Sales

279,967 million yen

291,310 million yen-

Operating income

17,700 million yen

8,223 million yen-

Ordinary income

22,190 million yen

21,610 million yen-

Current net income

15,849 million yen

16,378 million yen-

Current net income per share

117.42 yen--

Dividend per share

51.10 yen--(Note) Results for the term ended March 31, 2017 have been omitted because the company was not listed
and because information was not disclosed.
24.

Schedule(1) Date of resolution by board of directors

January 26, 2018

(2) Date of conclusion of basic agreement

January 26, 2018

5.

Future forecast

The effects on our consolidated performance for the term ending December 31, 2018, are now being
scrutinized. You will soon be informed of matters to be disclosed if any.
(Reference) Forecasted operating performance for the current term (released on January 24, 2018) andactual operating performance for the previous term

Sales

Operating income

Ordinary income(million yen)
Net income

Forecasted operating
performance for the currentterm (Term ended onDecember 31, 2017)

3,280

590

590

410

Actual operating
performance for theprevious term (Term endedon December 31, 2016)

3,288

724

724

499

3